Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Evolutionary Medicine, Energy Regulation and the Pathogenesis of Systemic Chronic Inflammatory DiseasesFebruary 23, 2011
Major Depressive Disorder, Immunoregulation, Inflammation and Our Changing Microbial EnvironmentNovember 4, 2011
The Nervous System’s Relationship to Immune Events: ‘Broadly Based but Cell-Faced’ – ‘wAPC’ as Hardwired Antigen Presenting CellsDecember 2, 2016
Pro-Inflammatory Th17 Cells and Glucocorticoid Resistance: Implications for Chronic Inflammatory Diseases and Their TreatmentMay 16, 2017
